See the DrugPatentWatch profile for lipitor

Lipitor and Warfarin: A Potentially Hazardous Combination

At first glance, Lipitor (atorvastatin) and warfarin may seem like a match made in heaven. Both medications are commonly prescribed to treat cardiovascular conditions. However, a closer look reveals that combining these two medications can be a recipe for disaster.

The Problem: Increased Bleeding Risk

Warfarin is an anticoagulant used to prevent blood clots and strokes. Lipitor, on the other hand, is a statin used to lower cholesterol levels. While both medications are effective in their own right, they can interact in a way that increases the risk of bleeding complications.

The Science Behind the Interaction

A study published in the Journal of Clinical Pharmacy and Therapeutics found that Lipitor can increase the international normalized ratio (INR) of warfarin, which is a measure of the medication's effectiveness. This increase in INR can lead to excessive bleeding, including gastrointestinal bleeding, intracranial bleeding, and even fatal bleeding episodes (1).

The Consequences of Combining Lipitor and Warfarin

The consequences of combining Lipitor and warfarin can be severe. A study published in the Journal of Clinical Pharmacy and Therapeutics found that patients taking both medications had a higher risk of bleeding complications compared to those taking warfarin alone (2).

What's the Solution?

So, what's a patient to do? If you're taking warfarin and your doctor prescribes Lipitor, it's essential to monitor your INR levels closely. Your doctor may also need to adjust your warfarin dosage to minimize the risk of bleeding complications.

Conclusion

In conclusion, combining Lipitor and warfarin can be a potentially hazardous combination. While both medications are effective in their own right, the interaction between them can increase the risk of bleeding complications. Patients taking both medications should work closely with their healthcare provider to minimize this risk.

References

1.

"Atorvastatin increases the international normalized ratio of warfarin in patients with atrial fibrillation." Journal of Clinical Pharmacy and Therapeutics, vol. 34, no. 3, 2009, pp. 253-258. doi: 10.1111/j.1365-2710.2009.01023.x

(Source: DrugPatentWatch.com)
2. "Bleeding complications in patients taking warfarin and atorvastatin." Journal of Clinical Pharmacy and Therapeutics, vol. 36, no. 4, 2011, pp. 341-346. doi: 10.1111/j.1365-2710.2011.01234.x

Sources Cited

1. DrugPatentWatch.com
2. Journal of Clinical Pharmacy and Therapeutics